Structure de mise en forme 2 colonnes

Integration of novel NANOparticle based technology for THERapeutics and diagnosis of different types of cancer


Nanother aims to successfully transform polymer nanomaterials into nanocarriers via biofunctionalisation (the linking of antibodies & ligands for detection), the binding of tumour cells, and the linking, delivery and release of therapeutic agents to treat the targeted tumour cells.


Nanother aims to select the best nanocarriers throughout the project by rigorously testing toxicity, biocompatibility, efficacy and biodistribution as an integral part of the selection process in order to continue developing only the most efficient, biocompatible and least toxic nanoparticles. The nanocarriers selected will be further developed and scaled-up, giving future exploitable nanoproducts.



The Brochure